CLIA Kit for Cat Eye Syndrome Chromosome Region, Candidate 1 (CECR1)

IDGFL; ADGF; ADA2; Cat Eye Syndrome Critical Region Protein 1

  • CLIA Kit for Cat Eye Syndrome Chromosome Region, Candidate 1 (CECR1) Packages (Simulation)
  • CLIA Kit for Cat Eye Syndrome Chromosome Region, Candidate 1 (CECR1) Packages (Simulation)
  • CLIA Kit for Cat Eye Syndrome Chromosome Region, Candidate 1 (CECR1) Results demonstration
  • SCL307Hu.jpg Typical Standard Curve
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

Specificity of the CLIA Kit for Cat Eye Syndrome Chromosome Region, Candidate 1 (CECR1)

This assay has high sensitivity and excellent specificity for detection of Cat Eye Syndrome Chromosome Region, Candidate 1 (CECR1).
No significant cross-reactivity or interference between Cat Eye Syndrome Chromosome Region, Candidate 1 (CECR1) and analogues was observed.

Recovery of the CLIA Kit for Cat Eye Syndrome Chromosome Region, Candidate 1 (CECR1)

Matrices listed below were spiked with certain level of recombinant Cat Eye Syndrome Chromosome Region, Candidate 1 (CECR1) and the recovery rates were calculated by comparing the measured value to the expected amount of Cat Eye Syndrome Chromosome Region, Candidate 1 (CECR1) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 78-93 83
EDTA plasma(n=5) 98-105 102
heparin plasma(n=5) 96-103 101

Precision of the CLIA Kit for Cat Eye Syndrome Chromosome Region, Candidate 1 (CECR1)

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Cat Eye Syndrome Chromosome Region, Candidate 1 (CECR1) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Cat Eye Syndrome Chromosome Region, Candidate 1 (CECR1) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity of the CLIA Kit for Cat Eye Syndrome Chromosome Region, Candidate 1 (CECR1)

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Cat Eye Syndrome Chromosome Region, Candidate 1 (CECR1) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 82-90% 96-103% 78-104% 88-95%
EDTA plasma(n=5) 78-88% 99-105% 85-99% 88-102%
heparin plasma(n=5) 78-99% 88-99% 88-102% 93-102%

Stability of the CLIA Kit for Cat Eye Syndrome Chromosome Region, Candidate 1 (CECR1)

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Assay procedure summary of the CLIA Kit for Cat Eye Syndrome Chromosome Region, Candidate 1 (CECR1)

1. Prepare all reagents, samples and standards;
2. Add 100µL standard or sample to each well. Incubate 1 hours at 37°C;
3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 3 times;
5. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
6. Aspirate and wash 5 times;
7. Add 100µL Substrate Solution. Incubate 10 minutes at 37°C;
8. Read RLU value immediately.

Test principle of the CLIA Kit for Cat Eye Syndrome Chromosome Region, Candidate 1 (CECR1)

The microplate provided in this kit has been pre-coated with an antibody specific to Cat Eye Syndrome Chromosome Region, Candidate 1 (CECR1). Standards or samples are then added to the appropriate microplate wells with a biotin-conjugated antibody specific to Cat Eye Syndrome Chromosome Region, Candidate 1 (CECR1). Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. Then the mixture of substrate A and B is added to generate glow light emission kinetics. Upon plate development, the intensity of the emitted light is proportional to the Cat Eye Syndrome Chromosome Region, Candidate 1 (CECR1) level in the sample or standard.;

Related products

Catalog No. Organism species: Homo sapiens (Human) Applications (RESEARCH USE ONLY!)
RPL307Hu01 Recombinant Cat Eye Syndrome Chromosome Region, Candidate 1 (CECR1) Positive Control; Immunogen; SDS-PAGE; WB.
PAL307Hu01 Polyclonal Antibody to Cat Eye Syndrome Chromosome Region, Candidate 1 (CECR1) WB; IHC; ICC; IP.
LAL307Hu71 Biotin-Linked Polyclonal Antibody to Cat Eye Syndrome Chromosome Region, Candidate 1 (CECR1) WB; IHC; ICC.
MAL307Hu21 Monoclonal Antibody to Cat Eye Syndrome Chromosome Region, Candidate 1 (CECR1) WB; IHC; ICC; IP.
SEL307Hu ELISA Kit for Cat Eye Syndrome Chromosome Region, Candidate 1 (CECR1) Enzyme-linked immunosorbent assay for Antigen Detection.
SCL307Hu CLIA Kit for Cat Eye Syndrome Chromosome Region, Candidate 1 (CECR1) Chemiluminescent immunoassay for Antigen Detection.
LML307Hu Multiplex Assay Kit for Cat Eye Syndrome Chromosome Region, Candidate 1 (CECR1) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.
GUESTBOOK